$AMGN

AI Analysis

Generated on May 11, 2026

AI Score
72/ 100
Hold$AMGN

Amgen Inc.

$AMGNNASDAQHealthcareMega-Cap

Amgen is a biotechnology company that discovers, develops, and delivers innovative medicines for serious illnesses.

Market Cap
$155.0B
Revenue (TTM)
$33.4B
+22.0%
Net Income (TTM)
$6.1B
+18.0%
EPS (TTM)
$11.20
P/E Ratio
26.0
Dividend Yield
3.0%
52-Week Range
$245-$340
Beta
0.55
Dimension Scores
Fundamental
74
Technical
66
Sentiment
70
Risk / Reward
74
Momentum
66
FundTechSentRiskMome
Financial Health
Profitability
79strong
Growth
69moderate
Liquidity
82strong
Solvency
76strong
Efficiency
72strong

Valuation, technical analysis, investment thesis, risk assessment and more for $AMGN

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.